Rapid influenza diagnostic tests market size is anticipated to witness a phenomenal growth in the upcoming years owing to the rising prevalence of infectious diseases and viral infections. According to the CDC estimates, influenza has induced between 9 million to 45 million illnesses, over 140,000 to 810,000 hospitalizations, and nearly more than 60 thousand deaths worldwide. This count has generated an oscillating demand for rapid influenza diagnostic tests.

It has been predicted that the global rapid influenza diagnostic tests market is poised to record a valuation of USD 689 million by the end of 2025, owing to the product’s umpteen advantages like accurate detection and diagnosis of viral infections and flu.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/4329  

The global rapid influenza diagnostic tests industry is fragmented into vivid segments including the product domain, patients, end-use landscape, and a robust regional outlook.

When speaking of the product segmentation, the global market is characterized by RIDT for influenza A sector, which in the yesteryear accounted for a business share of USD 352.5 million and is further expected to propel at a significant pace in the years to come. This growth can aptly be ascribed to mounting prevalence of flu and infection diseases in conjugation with the expanding geriatric patient pool. In line with this, the rising need for influenza treatment has also escalated the demand for the product.

The pediatric segment has been witnessing a massive demand spurt for RIDT, attributing to the fact that incidence of influenza across the pediatric population has gradually escalated over the years. Supporting the aforesaid, NSW Government puts forth a citation that over 192 of 100,000 children aged between 0 to 5 months require hospitalization on a monthly basis.

The severity of influenza in pediatric patients is relatively more compared to that in adults and geriatric population base. As per numerous reports, the segment is likely to grow at a rate of 7.5 per cent through 2025.

Request for customization @ https://www.decresearch.com/roc/4329

Rapid influenza diagnostic tests market across diagnostics centers have been garnering tremendous gains over the recent years, credited to a substantial rise in the number of influenza testing amongst geriatric populations and children.

Patients have been preferably opting for diagnostic centers owing to the fact that these spaces offer varied pathological tests due to robust convenience and diagnosis for treatment of viral infections and flues. Additionally, advantages like hospitalized infrastructure and specialized services are also likely to accentuate the demand for PIDT procedures in diagnostic centers.

The global RIDT industry is diversified into various economies including the U.S, Canada, India, Germany, and others. Below mentioned are the factors highlighting the growth trends across these regions.

 Canada rapid influenza diagnostic tests market is predicted to expand at an unprecedented growth rate of 7.3 per cent through 2025, perhaps due to the rising awareness and increased hospitalization rate nationwide. Speaking of influenza cases in the country, Infection Control and Prevention, Canada, had illustrated that nearly 55,000 patients were diagnosed with influenza in 2018. Driven by the rising cognizance pertaining to the prevention of contagious diseases, common cold, and flu amongst the Canadian population, RIDT industry across the country would grow prolifically over the forecast time frame.

Partial Chapter of the Table of Content

Chapter 2.  Executive Summary

2.1. Rapid influenza diagnostic tests industry 360⁰ synopsis, 2014 - 2025 (USD Million)

2.1.1.   Business trends

2.1.2.   Product trends

2.1.3.   Patient trends

2.1.4.   End-use trends

2.1.5.   Regional trends

Chapter 3.  Rapid Influenza Diagnostic Tests Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2025 (USD Million)

3.3. Industry impact factors

3.3.1.  Growth drivers

3.3.1.1.    Growing prevalence of influenza

3.3.1.2.    Increase in R&D activities

3.3.1.3.    Rise in demand for rapid diagnostic tests

3.3.1.4.    Greater specificity of rapid influenza diagnostic tests

3.3.2.  Industry pitfalls & challenges

3.3.2.1.    Lack of skilled professionals

3.3.2.2.    Stringent regulatory guidelines

3.3.2.3.    Rising healthcare costs

3.4. Growth potential analysis

3.4.1.  By product

3.4.2.  By patient

3.4.3.  By end-use

3.5. Porter’s analysis

3.6. Competitive landscape, 2018

3.6.1.    Strategy dashboard

3.7. PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/rapid-influenza-diagnostic-tests-ridt-market